PTC
SRNE

Philadelphia Trust Company’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Philadelphia Trust Company’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,600
Closed -$98K – 204
2020
Q2 		$98K Buy
+15,600
New +$98K 0.01% 168